Neuromodulatory drugs for the radical prostatectomy patient: Current and future applications

Autor:	Hugo H. Davila, J. Christopher Webster, Rafael Carrion, Justin Parker
Rok vydání:	2006
Předmět:	medicine.medical_specialty business.industry Prostatectomy Urology medicine.medical_treatment Obstetrics and Gynecology Erectile function Malignancy medicine.disease Safety profile Prostate cancer Erectile dysfunction Vasoactive medicine Intensive care medicine business Short duration
Zdroj:	Current Sexual Health Reports. 3:120-124
ISSN:	1548-3592 1548-3584
DOI:	10.1007/s11930-006-0014-6
Popis:	Prostate cancer is the most common noncutaneous malignancy in US men, with an estimated 232,000 new cases diagnosed in 2005. Radical prostatectomy (RP) has proved to be a safe and effective therapy for localized prostate cancer. However, RP can be associated with some risk of morbidity, which includes a potential compromise in erectile function. Medical therapies for erectile dysfunction after RP include vasoactive agents and neuromodulatory agents. This review evaluates the potential role of neuromodulatory agents in the post-RP patient. The potential of developing an agent that has a high safety profile and long duration of effectiveness makes these agents attractive alternatives for the future.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ab050b376e93ad8579f92c3f137f8490 https://doi.org/10.1007/s11930-006-0014-6 Zobrazit plný text záznamu Full text from SpringerLink